Related Experiment Videos
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and
M Mizuki1, R Fenski, H Halfter
1Department of Medicine/Hematology and Oncology, University of Münster, Germany.
Abstract:
Somatic mutations of the receptor tyrosine kinase Flt3 consisting of internal tandem duplications (ITD) occur in 20% of patients with acute myeloid leukemia. They are associated with a poor prognosis of the disease. In this study, we characterized the oncogenic potential and signaling properties of Flt3 mutations. We constructed chimeric molecules that consisted of the murine Flt3 backbone and a 510-base pair human Flt3 fragment, which contained either 4 different ITD mutants or the wild-type coding sequence. Flt3 isoforms containing ITD mutations (Flt3-ITD) induced factor-independent growth and resistance to radiation-induced apoptosis in 32D cells. Cells containing Flt3-ITD, but not those containing wild-type Flt3 (Flt3-WT), formed colonies in methylcellulose. Injection of 32D/Flt3-ITD induced rapid development of a leukemia-type disease in syngeneic mice. Flt3-ITD mutations exhibited constitutive autophosphorylation of the immature form of the Flt3 receptor. Analysis of the involved signal transduction pathways revealed that Flt3-ITD only slightly activated the MAP kinases Erk1 and 2 and the protein kinase B (Akt) in the absence of ligand and retained ligand-induced activation of these enzymes. However, Flt3-ITD led to strong factor-independent activation of STAT5. The relative importance of the STAT5 and Ras pathways for ITD-induced colony formation was assessed by transfection of dominant negative (dn) forms of these proteins: transfection of dnSTAT5 inhibited colony formation by 50%. Despite its weak constitutive activation by Flt3-ITD, dnRas also strongly inhibited Flt3-ITD-mediated colony formation. Taken together, Flt3-ITD mutations induce factor-independent growth and leukemogenesis of 32D cells that are mediated by the Ras and STAT5 pathways. (Blood. 2000;96:3907-3914)
Insights
Flt3-ITD mutations in acute myeloid leukemia drive cancer growth and survival. These mutations activate STAT5 and Ras pathways, leading to leukemia development and resistance to apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Hematology
Background:
- Somatic mutations in Flt3, specifically internal tandem duplications (ITD), are found in 20% of acute myeloid leukemia (AML) patients.
- Flt3-ITD mutations are associated with a poor prognosis in AML.
Purpose of the Study:
- To characterize the oncogenic potential and signaling properties of Flt3 mutations.
- To investigate the role of Flt3-ITD in factor-independent growth, apoptosis resistance, and leukemogenesis.
Main Methods:
- Constructed chimeric Flt3 molecules with ITD mutants or wild-type sequence.
- Assessed cellular transformation, apoptosis resistance, and tumor formation in mice.
- Analyzed signal transduction pathways including MAP kinases (Erk1/2), Akt, STAT5, and Ras.
Main Results:
- Flt3-ITD induced factor-independent growth and resistance to radiation-induced apoptosis in 32D cells.
- Flt3-ITD cells formed colonies in methylcellulose and induced leukemia in mice.
- Flt3-ITD exhibited constitutive STAT5 activation and ligand-independent activation of Ras pathways, mediating leukemogenesis.
Conclusions:
- Flt3-ITD mutations promote factor-independent growth and leukemogenesis.
- The Ras and STAT5 signaling pathways are crucial mediators of Flt3-ITD-induced cellular transformation and leukemia development.